A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Ozagrel Impurity G | Ozagrel Impurity G. Uses: For analytical and research use. Alternative Names: Ozagrel Methyl Ester; (E)-methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate. CAS No. 866157-50-8. Molecular formula: C14H14N2O2. Mole weight: 242.27. Catalog: APB866157508. |  |
| Ozagrel sodium | Ozagrel sodium. Group: Biochemicals. Grades: Highly Purified. CAS No. 189224-26-8,130952-46-4. Pack Sizes: 50mg, 100g, 250g, 500g, 1kg. US Biological Life Sciences. |  Worldwide |
| Ozanezumab | Ozanezumab (GSK1223249) is a humanized, Fc-inactivated monoclonal antibody that targets the nervous system protein Nogo-A. Ozanezumab promotes neurite outgrowth and axonal regeneration by neutralizing Nogo-A signaling. Ozanezumab is used for research on neurodegenerative diseases such as amyotrophic lateral sclerosis and multiple sclerosis[1][2][3]. Uses: Scientific research. Category: Inhibitory antibodies. Alternative Names: GSK1223249. CAS No. 1310680-64-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99213. |  |
| Ozanimod | Ozanimod (RPC-1063) is a CNS-penetrant sphingosine 1-phosphate (S1P) receptor modulator that binds with high affinity selectively to S1P receptor subtypes 1 (S1P1) and 5 (S1P5). Ozanimod has modulate effect for hS1P1 and hS1P5 receptor with EC50s of 1.03 nM and 8.6 nM, respectively. Ozanimod can be used for the research of relapsing multiple sclerosis (MS)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: RPC-1063. CAS No. 1306760-87-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12288. | |
| Ozanimod | Ozanimod is a medication used for the treatment of multiple sclerosis (MS) and inflammatory bowel disease (IBD), specifically ulcerative colitis. Ozanimod is a selective sphingosine 1-phosphate (S1P) receptor modulator. It binds to S1P receptors on lymphocytes (a type of white blood cell), thereby inhibiting their egress from lymph nodes. This action reduces the number of circulating lymphocytes that can cause inflammation in the central nervous system (in the case of MS) or the intestines (in the case of ulcerative colitis). Ozanimod is indicated for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It is also approved for the treatment of moderate to severe ulcerative colitis in adults who have not responded adequately to conventional therapies. Alternative Names: Benzonitrile, 5-[3-[(1S)-2,3-dihydro-1-[(2-hydroxyethyl)amino]-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-methylethoxy)-; 5-[3-[(1S)-2,3-Dihydro-1-[(2-hydroxyethyl)amino]-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-methylethoxy)benzonitrile; 5-[3-[1-(S)-(2-Hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-isopropoxybenzonitrile; RPC 1063; RPC-1063; RPC1063; Zeposia. Grades: ≥95%. CAS No. 1306760-87-1. Molecular formula: C23H24N4O3. Mole weight: 404.47. |  |
| Ozarelix | Ozarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors. Mechanistically, LHRH antagonists exert rapid inhibition of luteinizing hormone and follicle stimulating hormone with an accompanying rapid decrease in sex hormones and would therefore be expected to be effective in a variety of hormonally dependent disease states including ovarian cancer, prostate cancer, BPH, infertility, uterine myoma and endometriosis. BPH is a non-cancerous enlargement of the prostate that is caused by testosterone. Unlike LHRH agonists, ozarelix has the potential to reduce testosterone just enough to reduce both prostate size and symptoms without the severe side effects associated with a reduction in testosterone. Alternative Names: D 63153; D-63 153; D-63153; D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-norleucyl-L-arginyl-L-prolyl-. CAS No. 295350-45-7. Molecular formula: C72H96ClN17O14. Mole weight: 1459.11. | |
| Ozarelix acetate | Ozarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors. Alternative Names: D-63153 acetate; D 63153 acetate; D63153 acetate. CAS No. 896710-46-6. Molecular formula: C74H100ClN17O16. Mole weight: 1519.17. | |
| Ozekibart | Ozekibart (INBRX-109) is a DR5 agonist and antitumor agent with a human DR5 IC50 of 0.17 nmol/L and human DR5 Ka of 0.11 nmol/L. Ozekibart can be used for the research of unresectable/metastatic chondrosarcoma[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: INBRX-109. CAS No. 2539847-03-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990715. | |
| Ozenoxacin | Ozenoxacin is a novel topical antibacterial agent in the class of quinolone. Its 1% topical cream is approved for the treatment of impetigo in Canada and US. Alternative Names: 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)pyridin-3-yl]-4-oxoquinoline-3-carboxylic acid. CAS No. 245765-41-7. Molecular formula: C21H21N3O3. Mole weight: 363.4. | |
| Ozenoxacin Impurity 1 | Ozenoxacin Impurity 1. Uses: For analytical and research use. Molecular formula: C16H17Cl2NO3. Mole weight: 342.22. Catalog: APB11994. | |
| Ozenoxacin Impurity 10 | Ozenoxacin Impurity 10. Uses: For analytical and research use. CAS No. 103877-20-9. Molecular formula: C14H12ClNO3. Mole weight: 277.7. Catalog: APB103877209. | |
| Ozenoxacin Impurity 11 | Ozenoxacin Impurity 11. Uses: For analytical and research use. Molecular formula: C14H13Cl2NO3. Mole weight: 314.16. Catalog: APB12001. | |
| Ozenoxacin Impurity 12 | Ozenoxacin Impurity 12. Uses: For analytical and research use. Molecular formula: C15H17Cl2NO3. Mole weight: 330.21. Catalog: APB12000. | |
| Ozenoxacin Impurity 13 | Ozenoxacin Impurity 13. Uses: For analytical and research use. Molecular formula: C13H13Cl2NO3. Mole weight: 302.15. Catalog: APB11999. | |
| Ozenoxacin Impurity 14 | Ozenoxacin Impurity 14. Uses: For analytical and research use. Molecular formula: C28H26N4O2. Mole weight: 450.54. Catalog: APB12002. | |
| Ozenoxacin Impurity 15 | Ozenoxacin Impurity 15. Uses: For analytical and research use. CAS No. 446299-81-6. Molecular formula: C14H15BN2O3. Mole weight: 270.1. Catalog: APB446299816. | |
| Ozenoxacin Impurity 16 | Ozenoxacin Impurity 16. Uses: For analytical and research use. CAS No. 1111637-92-3. Molecular formula: C13H21BN2O2. Mole weight: 248.13. Catalog: APB1111637923. | |
| Ozenoxacin Impurity 17 | Ozenoxacin Impurity 17. Uses: For analytical and research use. Molecular formula: C28H26N2O6. Mole weight: 486.52. Catalog: APB12005. | |
| Ozenoxacin Impurity 18 | Ozenoxacin Impurity 18. Uses: For analytical and research use. Molecular formula: C28H26ClN3O4. Mole weight: 503.98. Catalog: APB12003. | |
| Ozenoxacin Impurity 19 | Ozenoxacin Impurity 19. Uses: For analytical and research use. Molecular formula: C27H26ClN3O4. Mole weight: 491.97. Catalog: APB12004. | |
| Ozenoxacin Impurity 2 | Ozenoxacin Impurity 2. Uses: For analytical and research use. Molecular formula: C16H17Cl2NO3. Mole weight: 342.22. Catalog: APB11995. | |
| Ozenoxacin Impurity 20 | Ozenoxacin Impurity 20. Uses: For analytical and research use. Molecular formula: C20H21N3O. Mole weight: 319.41. Catalog: APB12007. | |
| Ozenoxacin Impurity 21 | Ozenoxacin Impurity 21. Uses: For analytical and research use. Molecular formula: C21H21N3O4. Mole weight: 379.42. Catalog: APB12006. | |
| Ozenoxacin Impurity 22 | Ozenoxacin Impurity 22. Uses: For analytical and research use. Molecular formula: C21H21N3O4. Mole weight: 379.42. Catalog: APB12008. | |
| Ozenoxacin Impurity 23 | Ozenoxacin Impurity 23. Uses: For analytical and research use. Molecular formula: C20H21N3O2. Mole weight: 335.41. Catalog: APB12010. | |
| Ozenoxacin Impurity 24 | Ozenoxacin Impurity 24. Uses: For analytical and research use. Molecular formula: C20H21N3O2. Mole weight: 335.41. Catalog: APB12009. | |
| Ozenoxacin Impurity 25 | Ozenoxacin Impurity 25. Uses: For analytical and research use. CAS No. 302948-99-8. Molecular formula: C13H12ClNO3. Mole weight: 265.69. Catalog: APB302948998. | |
| Ozenoxacin Impurity 26 | Ozenoxacin Impurity 26. Uses: For analytical and research use. Molecular formula: C28H25N3O4. Mole weight: 467.53. Catalog: APB12012. | |
| Ozenoxacin Impurity 27 | Ozenoxacin Impurity 27. Uses: For analytical and research use. CAS No. 446299-90-7. Molecular formula: C30H29N3O4. Mole weight: 495.58. Catalog: APB446299907. | |
| Ozenoxacin Impurity 3 | Ozenoxacin Impurity 3. Uses: For analytical and research use. Molecular formula: C16H17Cl2NO3. Mole weight: 342.22. Catalog: APB11996. | |
| Ozenoxacin Impurity 4 | Ozenoxacin Impurity 4. Uses: For analytical and research use. Molecular formula: C16H17Cl2NO3. Mole weight: 342.22. Catalog: APB11997. | |
| Ozenoxacin Impurity 5 | Ozenoxacin Impurity 5. Uses: For analytical and research use. Molecular formula: C16H17Cl2NO3. Mole weight: 342.22. Catalog: APB11998. | |
| Ozenoxacin Impurity 6 | Ozenoxacin Impurity 6. Uses: For analytical and research use. CAS No. 245765-66-6. Molecular formula: C7H9BrN2. Mole weight: 201.07. Catalog: APB245765666. | |
| Ozenoxacin Impurity 7 | Ozenoxacin Impurity 7. Uses: For analytical and research use. CAS No. 856836-09-4. Molecular formula: C14H14N2O. Mole weight: 226.28. Catalog: APB856836094. | |
| Ozenoxacin Impurity 8 | Ozenoxacin Impurity 8. Uses: For analytical and research use. Alternative Names: N,N'-(5,5'-dimethyl-[3,3'-bipyridine]-6,6'-diyl)bis(N-methylbenzamide). Molecular formula: C28H26N4O2. Mole weight: 450.53. Catalog: APB01363. | |
| Ozenoxacin Impurity 8 | Ozenoxacin Impurity 8. Uses: For analytical and research use. CAS No. 29241-60-9. Molecular formula: C6H5BrClN. Mole weight: 206.47. Catalog: APB29241609. | |
| Ozenoxacin Impurity 9 | Ozenoxacin Impurity 9. Uses: For analytical and research use. CAS No. 103877-38-9. Molecular formula: C16H17Cl2NO3. Mole weight: 342.22. Catalog: APB103877389. | |
| O-Z-L-tyrosine | O-Z-L-tyrosine. Alternative Names: L-Tyr(Z)-OH; (S)-2-Amino-3-(4-(((Benzyloxy)Carbonyl)Oxy)Phenyl)Propanoic Acid. Grades: ≥ 98% (HPLC). CAS No. 21106-04-7. Molecular formula: C17H17NO5. Mole weight: 315.30. | |
| O-Z-L-tyrosine | O-Z-L-tyrosine. Group: Biochemicals. Alternative Names: L-Tyr(Z)-OH. Grades: Highly Purified. CAS No. 21106-04-7. Pack Sizes: 500mg, 1g, 2g, 5g, 10g. US Biological Life Sciences. | Worldwide |
| O-Z-L-tyrosine 99+% | O-Z-L-tyrosine 99+%. Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 1g, 5g, 25g. US Biological Life Sciences. | Worldwide |
| Ozonil | Ozonil. CAS No. 22629-49-8. VIGON Item # 502526. Categories: Speciality Ingrdients Suppliers, Fragrances, Perfumers, waxy nitrile. |  America & Internationally |
| Ozoralizumab | Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ATN-103; PF-5230896. CAS No. 1167985-17-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99796. | |
| Ozureprubart | HY-P990936 is an IGHE-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001)[1]. Uses: Scientific research. Category: Inhibitory antibodies. Alternative Names: JYB-1904; RPT904. CAS No. 2823332-50-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990936. | |
| Ozuriftamab | Ozuriftamab is a human IgG1 kappa antibody of ROR2. Ozuriftamab can be used to synthesize ADC such as Ozuriftamab vedotin (HY-145627). Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BA302. CAS No. 2460399-44-2. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-145626. | |
| Ozuriftamab vedotin | Ozuriftamab vedotin (BA3021), an antibody-drug conjugate (ADC), is a conditionally active biologic (CAB) anti-receptor tyrosine kinase orphan receptor 2 (ROR2) humanized monoclonal antibody Ozuriftamab (HY-145626) conjugated to VcMMAE (HY-15575). Ozuriftamab vedotin has antitumor activities[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BA3021; Anti-ROR2 ADC; CAB-ROR2-ADC. CAS No. 2460400-11-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-145627. | |
Our database is helping our users find suppliers everyday.
